The commercial activities are carried out by the Foundation’s wholly owned subsidiary, Novo Holdings A/S.
The Novo Nordisk Foundation aims to ensure that the companies in the Novo Group (Novo A/S, Novo Nordisk A/S and Novozymes A/S) position themselves as internationally recognised and leading actors in improving how disease is combated and how natural resources are used.
With Denmark as its centre of gravity, the Foundation’s focus is to improve the lives of people through better health, education and the development of a knowledge-based sustainable society.
The Novo Nordisk Foundation is a Danish commercial foundation that operates independently of any other interests than those described in the Foundation’s objects.
The Foundation is governed by the Danish Foundation Act, and the Danish Business Authority therefore supervises the Foundation.
The Novo Nordisk Foundation awards grants based on three established values or cornerstones: Commitment, Quality and Respect